ConductScience.org, home

Paper22013178

Anti-MuSK autoantibodies block binding of collagen Q to MuSK.

Kawakami Y and 9 others. Neurology, 2011. Cited by 95 papers, by iCite.

Cite this record

ConductScience Library. Anti-MuSK autoantibodies block binding of collagen Q to MuSK. Papers, record 22013178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22013178

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-MuSK autoantibodies block binding of collagen Q to MuSK.
PubMed
Journal
Neurology
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
95
iCite
Relative citation ratio, by iCite
2.72
iCite
Revised in PubMed
2025-10-26
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kawakami YY
2Ito MM
3Hirayama MM
4Sahashi KK
5Ohkawara BB
6Masuda AA
7Nishida HH
8Mabuchi NN
9Engel AGA G
10Ohno KK

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcetylcholinesteraseMajor topic
Antibodies, BlockingMajor topic
AutoantibodiesMajor topic
Binding Sites, AntibodyMajor topic
CollagenMajor topic
Muscle ProteinsMajor topic
Receptor Protein-Tyrosine KinasesMajor topic
Receptors, CholinergicMajor topic
Animals
Mice
Mice, Knockout
Myasthenia Gravis, Autoimmune, Experimental

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 NS006277NINDS NIH HHSUnited StatesR01NS006277PubMedNIH RePORTER
R56 NS006277NINDS NIH HHSUnited StatesR56NS006277PubMedNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in22013184Myasthenia gravis with antibodies to MuSK: another step toward solving mystery?https://conductscience.org/library/papers/22013184

Source PubMed

Download CSV of comments and corrections

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116557298Induction of myasthenia by immunization against muscle-specific kinase.J Clin Invest2006https://conductscience.org/library/papers/16557298PubMed
28653786The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo.Cell1996https://conductscience.org/library/papers/8653786PubMed
320603331Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice.J Physiol2010https://conductscience.org/library/papers/20603331PubMed
417081697Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis.Neuroscience2006https://conductscience.org/library/papers/17081697PubMed
512821509Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.Brain2003https://conductscience.org/library/papers/12821509PubMed
615668981Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.Ann Neurol2005https://conductscience.org/library/papers/15668981PubMed
716275854Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG.Neurology2005https://conductscience.org/library/papers/16275854PubMed
821255125MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity.Eur J Neurosci2011https://conductscience.org/library/papers/21255125PubMed
910087275Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function.J Cell Biol1999https://conductscience.org/library/papers/10087275PubMed
1012821744Clinical aspects of MuSK antibody positive seronegative MG.Neurology2003https://conductscience.org/library/papers/12821744PubMed
1116794080The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.Science2006https://conductscience.org/library/papers/16794080PubMed
1212684510Two different heparin-binding domains in the triple-helical domain of ColQ, the collagen tail subunit of synaptic acetylcholinesterase.J Biol Chem2003https://conductscience.org/library/papers/12684510PubMed
1318384168Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.Ann Neurol2008https://conductscience.org/library/papers/18384168PubMed
1410330416Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan.J Cell Biol1999https://conductscience.org/library/papers/10330416PubMed
1518957220LRP4 serves as a coreceptor of agrin.Neuron2008https://conductscience.org/library/papers/18957220PubMed
1620651592Autoimmune mediated neuromuscular junction defects.Curr Opin Neurol2010https://conductscience.org/library/papers/20651592PubMed
18831074Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.N Engl J Med1977https://conductscience.org/library/papers/831074PubMed
1920215342To build a synapse: signaling pathways in neuromuscular junction assembly.Development2010https://conductscience.org/library/papers/20215342PubMed
2015159418MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction.J Cell Biol2004https://conductscience.org/library/papers/15159418PubMed
2115048899Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.Ann Neurol2004https://conductscience.org/library/papers/15048899PubMed

See all 36 referencesDownload CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.

PMIDTitleJournalYearIn PapersSource
41409222Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies.Front Neurol2025https://conductscience.org/library/papers/41409222PubMed
40156757Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress.BioDrugs2025https://conductscience.org/library/papers/40156757PubMed
39703505A clinical perspective on muscle specific kinase antibody positive myasthenia gravis.Front Immunol2024https://conductscience.org/library/papers/39703505PubMed
38911858Case report: Rapid clinical improvement in acute exacerbation of MuSK-MG with efgartigimod.Front Immunol2024https://conductscience.org/library/papers/38911858PubMed
38566882Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China.Neuropsychiatr Dis Treat2024https://conductscience.org/library/papers/38566882PubMed
37564637Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease.Front Immunol2023https://conductscience.org/library/papers/37564637PubMed
36835142Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review.Int J Mol Sci2023https://conductscience.org/library/papers/36835142PubMed
35002624Cholinesterases in Tripartite Neuromuscular Synapse.Front Mol Neurosci2021https://conductscience.org/library/papers/35002624PubMed
34233932Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis.Neurology2021https://conductscience.org/library/papers/34233932PubMed
33927677Afterdischarges in Myasthenia Gravis.Front Neurol2021https://conductscience.org/library/papers/33927677PubMed
33329350Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management.Front Neurol2020https://conductscience.org/library/papers/33329350PubMed
33123066Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China.Front Neurol2020https://conductscience.org/library/papers/33123066PubMed
32982689Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment.Front Mol Neurosci2020https://conductscience.org/library/papers/32982689PubMed
32547365Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability.Front Mol Neurosci2020https://conductscience.org/library/papers/32547365PubMed
32353380Multiple MuSK signaling pathways and the aging neuromuscular junction.Neurosci Lett2020https://conductscience.org/library/papers/32353380PubMed
32117321Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.Front Immunol2020https://conductscience.org/library/papers/32117321PubMed
31920954The Muscle Is Not a Passive Target in Myasthenia Gravis.Front Neurol2019https://conductscience.org/library/papers/31920954PubMed
31269763Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.Cells2019https://conductscience.org/library/papers/31269763PubMed
30882021MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity.Neurol Neuroimmunol Neuroinflamm2019https://conductscience.org/library/papers/30882021PubMed
29377160IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders.Ann N Y Acad Sci2018https://conductscience.org/library/papers/29377160PubMed

See all 43 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACHE43PubTator's text mininghttps://conductscience.org/library/genes/43NCBI Gene
AGRN375790PubTator's text mininghttps://conductscience.org/library/genes/375790NCBI Gene
COLQ8292PubTator's text mininghttps://conductscience.org/library/genes/8292NCBI Gene
MUSK4593PubTator's text mininghttps://conductscience.org/library/genes/4593NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22013178

GET https://conductscience.org/api/papers/v1/22013178/references?page=2